Cargando…
Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
OBJECTIVE: To evaluate the efficacy, safety, and prognostic value of low-dose apatinib in combination with temozolomide in the treatment of primary or recurrent high-grade gliomas (HGGs). METHODS: A retrospective analysis of patients with postoperative and recurrent HGGs treated in our hospital from...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467810/ https://www.ncbi.nlm.nih.gov/pubmed/36106030 http://dx.doi.org/10.1155/2022/3181133 |